Chaabouni Azza, Boubaker Elandoulsi Ramzi, Mhadhbi Moez, Gharbi Mohamed, Sassi Atfa
Laboratory of BioInformatics, BioMathematics and BioStatistics, LR16 IPT09, Institut Pasteur de Tunis, University Tunis El Manar, 1002, Tunisia.
Laboratory of Biotechnology and Bio-Geo Resources Valorization (LR11ES31), Higher Institute of Biotechnology, BiotechPôle, BP66, 2020, Sidi Thabet, University La Manouba, Tunisia.
Vet Parasitol. 2018 Sep 15;261:9-17. doi: 10.1016/j.vetpar.2018.07.011. Epub 2018 Jul 23.
Leishmania (L.) infantum-infected dogs may present with a large range of clinical signs, from apparently healthy with no or few (asymptomatic dogs, AD) to several clinical signs indicators of active infection (symptomatic dogs, SD). The present study is justified by the conflicting reports describing that either L. infantum-specific IgG1 or IgG2 antibodies may be used as isotype marker of the asymptomatic infection status and by the lack, to our knowledge, of previous analysis of the IgG sub-classes autoantibody repertoires of Leishmania-infected dogs. On the basis of clinical evaluation and laboratory testing (IFAT, parasitological examination of Giemsa-stained lymph node smears, L. infantum antigens-ELISA of total (Tot) IgG), 131 dogs were categorized as SD, asymptomatic seronegative (AND) or seropositive dogs (APD) from surrounding areas, and as negative control dogs (CTD). ELISA based on leishmanial native antigens or recombinant LACK and LeIF proteins showed that SD produce higher levels of specific Tot IgG, IgG1 and IgG2 antibodies than APD, and that for both clinical stages, the antibody titers of IgG2 isotype were constantly higher than those of the IgG1. The seroprevalences of Tot IgG, IgG2 did not differ between APD and SD groups (97 and 97% in SD; 100 and 96% in APD, respectively) whereas that of IgG1 was slightly lower in SD (88% of APD versus 82% of SD). The autoantibody repertoires were analyzed by ELISA using HEp-2 extracts, ds-DNA, human albumin and transferrin as self-antigens and by Western blot using HEp-2 proteins. ELISA results' indicated that APD develop higher levels of IgG1 autoantibodies, and higher seroprevalence (50% and 26% in APD and SD, respectively), contrasting with lower levels and seroprevalences of Tot IgG and IgG2 (43 and 68% for APD; 100 and 74% for SD). Interestingly, SD showed a stronger IgG1 and particularly IgG2 reactivity with transferrin, an iron-binding protein, than APD and AND. Western blotting experiments produced heterogeneous IgG1 and IgG2 inter- and intra-groups reactivity profiles towards HEp-2 proteins, to identify a specific antigenic profile. Generated data from competitive HEp-2-ELISA using leishmanial antigens as inhibitors were in favor that IgG1 antibodies are predominantly autoantibodies to self-antigens in APD whereas they are mainly cross-reactive (Leishmania/self-antigens) in SD.
感染婴儿利什曼原虫(Leishmania (L.) infantum)的犬只可能呈现出广泛的临床症状,从看似健康、无或仅有少数症状(无症状犬,AD)到多种活跃感染的临床症状指标(有症状犬,SD)。本研究的开展是基于相互矛盾的报告,这些报告描述婴儿利什曼原虫特异性IgG1或IgG2抗体均可作为无症状感染状态的同种型标志物,且据我们所知,此前缺乏对感染利什曼原虫犬只IgG亚类自身抗体库的分析。基于临床评估和实验室检测(间接荧光抗体试验(IFAT)、吉姆萨染色淋巴结涂片的寄生虫学检查、总(Tot)IgG的婴儿利什曼原虫抗原酶联免疫吸附测定(ELISA)),将131只犬分为有症状犬、无症状血清阴性犬(AND)或来自周边地区的血清阳性犬(APD),以及阴性对照犬(CTD)。基于利什曼原虫天然抗原或重组LACK和LeIF蛋白的ELISA显示,有症状犬产生的特异性总IgG、IgG1和IgG2抗体水平高于无症状血清阳性犬,并且在两个临床阶段,IgG2同种型的抗体滴度始终高于IgG1。总IgG、IgG2的血清阳性率在有症状犬组和无症状血清阳性犬组之间无差异(有症状犬组分别为97%和97%;无症状血清阳性犬组分别为100%和96%),而IgG1的血清阳性率在有症状犬组略低(无症状血清阳性犬组为88%,有症状犬组为82%)。通过使用人喉癌上皮细胞(HEp-2)提取物、双链DNA、人白蛋白和转铁蛋白作为自身抗原的ELISA以及使用HEp-2蛋白的蛋白质印迹法分析自身抗体库。ELISA结果表明,无症状血清阳性犬产生更高水平的IgG1自身抗体,且血清阳性率更高(无症状血清阳性犬组和有症状犬组分别为50%和26%),与之形成对比的是,总IgG和IgG2的水平及血清阳性率较低(无症状血清阳性犬组分别为43%和68%;有症状犬组分别为100%和74%)。有趣的是,与无症状血清阳性犬和无症状犬相比,有症状犬对转铁蛋白(一种铁结合蛋白)表现出更强的IgG1,尤其是IgG2反应性。蛋白质印迹实验产生了针对HEp-2蛋白的组间和组内异质性IgG1和IgG2反应谱,以确定特定的抗原谱。使用利什曼原虫抗原作为抑制剂的竞争性HEp-2-ELISA产生的数据表明,IgG1抗体在无症状血清阳性犬中主要是针对自身抗原的自身抗体,而在有症状犬中它们主要是交叉反应性的(利什曼原虫/自身抗原)。